| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.009 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |